The content on this site is intended for healthcare professionals only
At a press conference during the ASCO 2012 Annual Meeting in Chicago, June 1st - June 4th, Dr Eric Larsen presents results from a phase III study on the outcomes of high risk acute lymphoblastic leukaemia patients ages 16 to 30.
New classification for identifying HR myeloma based on cytogenetic abnormalities
Advancements in paediatric Acute lymphoblastic leukemia management
CAR-T - Choosing Wisely
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Psychological issues in familial cancer
Multiple myeloma In Rwanda: The need for further research
Bone disease evaluation of newly diagnosed MM with combined use of 18F-FDG PET/CT and whole-body diffusion weighted MRI
Multiple myeloma in a resource constrained setting
Relapsed refractory multiple myeloma
